Detection Of Monocytes/Macrophages Function And Tim-3 Expression In Septic Patients
NCT01801839 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1
Last updated 2016-01-28
Summary
The imbalance between anti- and pro-inflammation often occurs in patients with sepsis. And continuous such imbalance could lead to immunoparalysis, which is characterized by loss of delayed type hypersensitivity, failure of primary infections eradication, and a predisposition of secondary nosocomial infections development. However, in which phase of sepsis does immunoparalysis occur is still unknown. So this study aims to tentatively understand this problem by checking monocytes/macrophages' antigen presentation and cytokine secretion,and by checking monocytes/macrophages' expression of Tim-3 (the T cell transmembrane, immunoglobulin, and mucin-3), which is an inhibitory regulatory molecule, in sepsis patients' peripheral blood mononuclear cells.
Conditions
- Sepsis
- SIRS(Systemic Inflammatory Response Syndrome)
Sponsors & Collaborators
-
Chinese PLA General Hospital
lead OTHER
Principal Investigators
-
Lixin Xie, MD · Respiratory Disease Department of Chinese PLA General Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2012-08-31
- Primary Completion
- 2015-07-31
Countries
- China
Study Locations
More Related Trials
-
Co-inhibitory Molecules on Treg and miR-155-5p in Patients With Sepsis
NCT05126537 ·Status: UNKNOWN
-
Inflammatory Mediators in Early Sepsis
NCT02692118 ·Status: UNKNOWN
-
Comparison the Value of Several Biomarkers of Sepsis
NCT01388725 ·Status: COMPLETED
-
Dynamic Alterations of Th2/Th1 With New Onset of Community-acquired Severe Sepsis Patients
NCT02883218 ·Status: COMPLETED
-
Effect of Immunophenotype on Prognosis of Sepsis
NCT05602584 ·Status: UNKNOWN
-
Identification and Clinical Efficacy Analysis of Biomarkers in Sepsis Patients
NCT05911711 ·Status: UNKNOWN
-
Assessing Immune Dysfunction in Sepsis
NCT07154615 ·Status: RECRUITING
-
Mediators of Inflammation, Prognostic Markers and Genetic Polymorphisms in Patients With Sepsis
NCT01535534 ·Status: UNKNOWN
-
Study on the Role of Gamma Delta T Cells in Sepsis Immunosuppression and Its Molecular Mechanism
NCT02361970 ·Status: COMPLETED
-
Following of Myeloid-derived Suppressor Cells (MDSC) in Severe Sepsis: What Relationship With Systemic Inflammatory Syndrome?
NCT02903082 ·Status: TERMINATED
-
Urine Interleukin-37 as a Biomarker of Mortality Risk in Patients With Sepsis
NCT05640037 ·Status: COMPLETED
-
Towards Novel BIOmarkers to Diagnose SEPsis on the Emergency Room
NCT06178822 ·Status: RECRUITING
-
Immune Homeostasis in Sepsis and Septic Shock
NCT04448951 ·Status: RECRUITING
-
Host Dysregulation-Driven Sepsis Prediction Model
NCT06523075 ·Status: COMPLETED
-
TRIM25 in Septic Patients
NCT07320638 ·Status: ENROLLING_BY_INVITATION
-
Dysfunctional Myelopoiesis and Myeloid-Derived Suppressor Cells in Sepsis
NCT05110937 ·Status: RECRUITING
-
MiRNAs Evaluating Lymphocyte Proliferation and Apoptosis as Well as Prognosis of Sepsis
NCT02756559 ·Status: UNKNOWN
-
Platelet-associated Inflammation in Severe Sepsis
NCT03029039 ·Status: COMPLETED
-
Study on Antigen-presenting Function of Gamma Delta T Cells in Sepsis and Its Molecular Mechanisms
NCT03379896 ·Status: UNKNOWN
-
Monocyte Profiles in Critically Ill Patients With Pseudomonas Aeruginosa Sepsis
NCT03044223 ·Status: RECRUITING
-
Immune Function Monitoring and Immunotherapy in Sepsis
NCT04903405 ·Status: UNKNOWN
-
The Th9/IL-9 and Early Enteral Nutrition in Sepsis
NCT03791866 ·Status: UNKNOWN ·Phase: NA
-
Immune Profile of Patients With Sepsis
NCT04163705 ·Status: UNKNOWN
-
Risk Factors for Adverse Outcomes in Sepsis
NCT06541600 ·Status: COMPLETED
-
INFLAmmasomes NLRP3 in Platelets and Leukocytes During SEPSIS in Intensive Care Unit
NCT04635878 ·Status: COMPLETED